Clinical Trials Directory

Trials / Unknown

UnknownNCT04099550

Effect of Real-time Continuous Glucose Monitoring System in Overweight or Obese Adults With Prediabetes

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Pusan National University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

In Korea, 5 million adults aged 30 years or older have diabetes. The development and expansion of Korea's economy and society, has led to dramatic chances in people's lifestyle and diet habits, and an increase in life expectancy. However, changes in lifestyle and diet habits related to the improvements of socioeconomic status may contribute to an increased diabetes burden in Korea. Therefore, it is important to prevent diabetes. The purpose of this study was to evaluate the effects of real time-continuous glucose measurement (RT-CGM) system compared to only lifestyle modification group on blood glucose, lipid profile and diabetes prevention in prediabetic adults with overweight or obesity.

Detailed description

Optimising patient adherence to prescribed lifestyle interventions to achieve improved blood glucose control remains a challenge. Combined use of real-time continuous glucose monitoring (RT-CGM) systems may promote improved glycaemic control. Thirty adult with overweight or obesity and pre-diabetes are randomised to using either RT-CGM or self monitoring of blood glucose (SMBG) for 1 week with lifestyle intervention. After 3 month, outcomes were glycemic control (HbA1c, fasting glucose), weight, and lipid profile assessed pre- and post-intervention.

Conditions

Interventions

TypeNameDescription
DEVICERT-CGMThe group was monitored blood glucose initial 1-week with a RT-CGM.
OTHERSMBGThe group was monitored self-monitoring blood glucose (SMBG) at least 2 times a day for initial 1-week.

Timeline

Start date
2019-12-06
Primary completion
2020-12-01
Completion
2021-12-01
First posted
2019-09-23
Last updated
2020-04-24

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04099550. Inclusion in this directory is not an endorsement.